Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
This article helps you decide between taxable and tax-exempt bond funds in retirement, outlining allocation strategies and tax considerations.
25,011 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Best Buy surprised investors with a solid earnings beat and improving margins, sending the stock higher. This article...
Investors are weighing whether to buy AT&T before July 22. This guide breaks down the yield, headlines, and strategy ...
When a legendary investor shifts big positions, traders sit up. This piece breaks down what it could mean that billio...
The AI boom has turned Nvidia and AMD into poster children for opportunity—and risk. This guide breaks down the signa...
KRE has climbed on improving regional bank margins. If rates fall further, here’s how the scenario could shape earnin...
As AI expands, data-center construction flourishes. This piece explains why sterling infrastructure should regain mom...
Bitcoin breaks back above $68,000 to lead a crypto rebound, with Circle’s revenue surge and NEAR’s jump signaling sus...
Worthington Steel stock dropped today after the company reported solid revenue growth but weak earnings due to higher...
Marvell Technology recently reached a new high, prompting questions about its staying power. This guide breaks down t...
AppLovin shares slipped in June as software peers faced headwinds. This in-depth look explains the catalysts, how the...
A single headline can move stock in moments, but the real story is rarely a simple one. This article dives into why a...